10 Best Small Cap Stocks to Buy Now - 1 of 10

 
 

ChromaDex (NASDAQ:CDXC)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$5.87 (55.2% Upside)

About ChromaDex

ChromaDex logoChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/9/2024Roth MkmBoost Price TargetBuy ➝ Buy$4.25 ➝ $6.00
8/10/2023HC WainwrightReiterated RatingBuy ➝ Buy$5.00
5/11/2023LADENBURG THALM/SH SHLower Price Target$7.50 ➝ $6.60
3/13/2023HC WainwrightLower Price TargetBuy$5.50 ➝ $5.00
2/1/2023HC WainwrightReiterated RatingBuy$5.50
11/3/2022B. RileyLower Price Target$2.40 ➝ $2.10
8/29/2022HC WainwrightLower Price TargetBuy$7.00 ➝ $5.50
8/16/2022OppenheimerDowngradeOutperform ➝ Market Perform
8/11/2022B. RileyDowngradeBuy ➝ Neutral$6.00 ➝ $2.40
6/7/2022HC WainwrightLower Price TargetBuy$8.00 ➝ $7.00
 

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details